Tetrakit Technologies

TetraKit Technologies (2021) is a spin-off company originating from the University of Copenhagen (KU). Our mission is to revolutionize theranostic agent development through our unique chemistry - The TetraKit Platform. It allows for one-fits-all radiolabeling of most targeting vectors with optimal diagnostic and therapeutic radionuclides. We develop both, our core platform technology, as well as proprietary novel theranostic radiopharmaceuticals based on our platform. This technology is based on the latest advancements in click chemistry and radiolabeling techniques coming from our laboratories. We are interested in partnerships to combine our radiolabeling platform with emerging targeting vectors.